In 2019, a number of significant changes in the healthcare area were introduced, including, among other things, the extension of procurement by specialized procurement agencies until 31 March 2022, introduction of external reference pricing for certain pharmaceuticals sold at public tenders and imposition of stricter criminal liability for falsification of pharmaceuticals.
